Xylem has seen its share price slide over the past year, which puts fresh focus on whether the current US$102.66 level lines up with the cash the business is expected to generate. For anyone tracking the stock, the question now is how that weaker trading history squares with what a Discounted Cash Flow (DCF) view of its future cash streams suggests.
The issue now is whether Xylem's current share price is adequately supported by the cash flows implied by its intrinsic value estimate.
If you are weighing Xylem against other opportunities where valuation and business quality are in focus, it can help to compare it with companies in the 30 resilient stocks with low risk scores.
The Discounted Cash Flow (DCF) model here focuses on the cash Xylem can return to shareholders over time and what that stream might be worth today. On the latest twelve month view, the group generated roughly $940.2 million of free cash flow, so the market is weighing that cash engine against the current share price of $102.66.
Analyst projections used in this DCF imply growing free cash flow over the coming decade, moving from hundreds of millions of dollars today toward roughly $1.9b around 2030 in the base case. Those forecasts assume Xylem can keep scaling its cash generation rather than plateauing. This matters because the model currently puts its estimated intrinsic value substantially above the traded price. For anyone comparing Xylem with other industrials, the key question is whether that growth path in free cash is realistic enough to justify a valuation gap of that size. Find out what Xylem could be worth using our Discounted Cash Flow (DCF) estimate.
Narratives for Xylem pick up where the valuation puzzle leaves off by spelling out which specific views on growth, profitability and earnings would need to hold for the shares to be worth materially more or less than today’s price. They sit on Simply Wall St’s Community page, and each one links its number to a clear view of how Xylem's growth, margin profile and risk picture could evolve, giving you something concrete to revisit as new information emerges.
One of the top community narratives on Xylem: 33% undervalued
"Bullish analysts see Xylem as a direct beneficiary of rising AI related data center water needs, arguing that water is an underappreciated constraint..."
Discover why this Narrative puts Xylem at 33% undervalued.
Before you get too fixated on Xylem's cash flows and valuation outputs, it is worth asking who is actually running the business and how their pay packets line up with your interests. See who runs Xylem and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com